Xiaoluan Yan

580 total citations · 1 hit paper
33 papers, 363 citations indexed

About

Xiaoluan Yan is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoluan Yan has authored 33 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Hepatology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoluan Yan's work include Colorectal Cancer Treatments and Studies (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Xiaoluan Yan is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Xiaoluan Yan collaborates with scholars based in China, Ethiopia and United Kingdom. Xiaoluan Yan's co-authors include Baocai Xing, Kun Wang, Quan Bao, Da Xu, Kemin Jin, Yi Sun, Hongwei Wang, Bao-Cai Xing, Qinglong Jiang and Juan Li and has published in prestigious journals such as Nature Communications, Annals of Oncology and Annals of Surgical Oncology.

In The Last Decade

Xiaoluan Yan

31 papers receiving 363 citations

Hit Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenv... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoluan Yan China 11 238 215 111 75 48 33 363
Masaru Oba Japan 12 314 1.3× 264 1.2× 145 1.3× 121 1.6× 36 0.8× 30 400
Wendy Langeberg United States 2 354 1.5× 318 1.5× 172 1.5× 114 1.5× 48 1.0× 3 496
Pieter M. H. Nierop Netherlands 12 296 1.2× 255 1.2× 62 0.6× 53 0.7× 70 1.5× 18 390
Santhalingam Jegatheeswaran United Kingdom 6 162 0.7× 134 0.6× 69 0.6× 58 0.8× 22 0.5× 9 240
Julien Leporrier France 3 331 1.4× 326 1.5× 181 1.6× 98 1.3× 32 0.7× 3 439
William L. Horvath United States 6 333 1.4× 275 1.3× 106 1.0× 102 1.4× 40 0.8× 7 431
Jan Stoehlmacher-Williams Germany 8 260 1.1× 143 0.7× 155 1.4× 210 2.8× 65 1.4× 14 434
C. Barone Italy 7 247 1.0× 210 1.0× 78 0.7× 84 1.1× 20 0.4× 23 381
Michinori Hamaoka Japan 10 136 0.6× 190 0.9× 77 0.7× 55 0.7× 68 1.4× 38 283
Xuqi Sun China 8 115 0.5× 192 0.9× 69 0.6× 72 1.0× 71 1.5× 27 282

Countries citing papers authored by Xiaoluan Yan

Since Specialization
Citations

This map shows the geographic impact of Xiaoluan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoluan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoluan Yan more than expected).

Fields of papers citing papers by Xiaoluan Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoluan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoluan Yan. The network helps show where Xiaoluan Yan may publish in the future.

Co-authorship network of co-authors of Xiaoluan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoluan Yan. A scholar is included among the top collaborators of Xiaoluan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoluan Yan. Xiaoluan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hongwei, Qun Ma, Kemin Jin, et al.. (2025). The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial. Nature Communications. 16(1). 1443–1443. 17 indexed citations breakdown →
2.
Bao, Quan, Tingting Zhao, Longfei Huang, et al.. (2024). Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Hepatology International. 18(3). 1029–1039. 4 indexed citations
3.
Yan, Xiaoluan, Hongwei Wang, Kemin Jin, et al.. (2023). Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Medicine. 12(8). 9559–9569. 14 indexed citations
4.
Wang, Yanyan, Kun Wang, Quan Bao, et al.. (2023). Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study. European Journal of Surgical Oncology. 49(9). 106931–106931. 6 indexed citations
5.
Zhang, Jianan, Yan Chen, Xiaoluan Yan, et al.. (2022). Mean platelet volume modifies the contribution of homocysteine to cardiovascular disease: A real-world study. Nutrition Metabolism and Cardiovascular Diseases. 33(1). 194–202. 4 indexed citations
6.
Bao, Xuanwen, Kun Wang, Ming Liu, et al.. (2022). Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value. Frontiers in Cell and Developmental Biology. 9. 760618–760618. 31 indexed citations
7.
Bai, Long, Xiaoluan Yan, Yun‐Xin Lu, et al.. (2022). Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection. Annals of Surgical Oncology. 29(7). 4308–4323. 4 indexed citations
8.
Xu, Da, Yanyan Wang, Xiaoluan Yan, et al.. (2021). Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases. Journal of Gastrointestinal Oncology. 12(4). 1498–1508. 10 indexed citations
9.
Yan, Xiaoluan, Kun Wang, Quan Bao, et al.. (2021). En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum. BMC Surgery. 21(1). 302–302. 6 indexed citations
10.
Wang, Hongwei, Xiaoluan Yan, Lijun Wang, et al.. (2021). Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases. Journal of Translational Medicine. 19(1). 313–313. 8 indexed citations
11.
Wang, Kun, Hongwei Wang, Kemin Jin, et al.. (2021). Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases. Frontiers in Oncology. 11. 643375–643375. 3 indexed citations
12.
Zhang, Jianan, Jing Li, Xiaoluan Yan, et al.. (2020). Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients. International Journal of Hypertension. 2020. 1–8. 5 indexed citations
13.
Xu, Da, Xiaoluan Yan, Jia-Ming Liu, Juan Li, & Baocai Xing. (2020). The characteristics and long-term survival of patients with colorectal liver metastases with pathological complete response after chemotherapy. Journal of Cancer. 11(21). 6256–6263. 9 indexed citations
14.
Yan, Xiaoluan, et al.. (2020). <p>Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis</p>. Cancer Management and Research. Volume 12. 3237–3245. 3 indexed citations
15.
Xu, Da, Hongwei Wang, Xiaoluan Yan, et al.. (2019). Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases. European Journal of Surgical Oncology. 45(9). 1551–1558. 19 indexed citations
16.
Zhang, Zhongyi, et al.. (2018). Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World Journal of Surgical Oncology. 16(1). 207–207. 36 indexed citations
17.
Wang, Kun, Da Xu, Xiaoluan Yan, Graeme J. Poston, & Baocai Xing. (2018). The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis. European Journal of Surgical Oncology. 44(6). 771–777. 30 indexed citations
18.
Shen, Xiaobing, Jia Wang, Xiaoluan Yan, et al.. (2016). Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis. Cancer Chemotherapy and Pharmacology. 77(6). 1285–1302. 12 indexed citations
19.
Jin, Kemin, Xiaoluan Yan, Kun Wang, et al.. (2015). [Prognostic significance of clinical risk score system after resection of hepatic metastases from colorectal cancer].. PubMed. 37(12). 913–6. 1 indexed citations
20.
Shen, Xiaobing, Jia Wang, Peng‐Fei Li, et al.. (2014). Screening of susceptibility genes and multi-gene risk analysis in gastric cancer. Medical Oncology. 31(10). 196–196. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026